Given Imaging (GIVN) Announces Litigation Settlement with Olympus; Will Revise FY08 Earnings
More News related to GIVN
- Given Imaging to Present at the 6th Annual Lazard Capital Markets Healthcare Conference
- Susquehanna Maintains a 'Positive' on Given Imaging (GIVN); Still Possible Acquisition Target
- Leon Cooperman Raises Stake In Given Imaging (GIVN) Above 5%
- After-Hours Movers 11/04: RSOL, SANM, PARL, VLNC, GIVN, CECO Higher; SMSI, AUTH, WFMI, ANDE Lower
- Given Imaging (GIVN) Reports Q3 EPS of $0.20; Raises FY09 EPS Guidance
More News related to Corporate News
- S&P Announces Changes to US Index: CMN for NTG, CVGW for STSA
- Kinross (KGC) Enters Agreement for $125M Letter of Credit Facility
- Endo Pharma (ENDP) Announces Settlement with LecTec Over Outstanding Patent Litigation
- Trubion Pharma (TRBN) Announces Two Presentations of TRU-016 Product at 2009 ASH Meeting
- S&P Revises Outlook on Sirius XM (SIRI) from Stable to Positive
Given Imaging Ltd. (Nasdaq: GIVN) has signed the final settlement agreement with Olympus Corporation ending the patent litigation between the parties.
The Company is analyzing the applicable tax, if any, on the payment of $2.33 million to the Company, and will revise its 2008 fiscal year earnings per share guidance together with the release of the results of the second quarter of 2008.
Given Imaging Ltd. develops, manufactures and markets diagnostic products for the visualization and detection of disorders of the gastrointestinal tract. [SM]
Related Categories
Corporate NewsGuidance
Stocks Mentioned
+0.24Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
